Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshimasa Shinki

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Steroids|July 18, 2006
Characterization of rat and human CYP2J enzymes as Vitamin D 25-hydroxylasesIsamu Aiba, Tomoaki Yamasaki, Toshimasa Shinki, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 5, 2002
Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formationXinxiang Wang, Jian Wu, Yoshihiro Shidoji, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2006
Reveromycin A, an agent for osteoporosis, inhibits bone resorption by inducing apoptosis specifically in osteoclastsJe-Tae Woo, Makoto Kawatani, Masanori Kato, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Steroids|July 18, 2006
Characterization of rat and human CYP2J enzymes as Vitamin D 25-hydroxylasesIsamu Aiba, Tomoaki Yamasaki, Toshimasa Shinki, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 5, 2002
Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formationXinxiang Wang, Jian Wu, Yoshihiro Shidoji, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2006
Reveromycin A, an agent for osteoporosis, inhibits bone resorption by inducing apoptosis specifically in osteoclastsJe-Tae Woo, Makoto Kawatani, Masanori Kato, et al.
Pageof 2